A detailed history of Black Rock Inc. transactions in Exelixis, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 33,502,228 shares of EXEL stock, worth $1.13 Billion. This represents 0.02% of its overall portfolio holdings.

Number of Shares
33,502,228
Previous 34,882,633 3.96%
Holding current value
$1.13 Billion
Previous $828 Million 9.06%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$20.34 - $23.73 $28.1 Million - $32.8 Million
-1,380,405 Reduced 3.96%
33,502,228 $753 Million
Q1 2024

May 10, 2024

SELL
$20.17 - $23.93 $22.8 Million - $27.1 Million
-1,131,799 Reduced 3.14%
34,882,633 $828 Million
Q4 2023

Feb 13, 2024

SELL
$19.25 - $24.13 $19.5 Million - $24.4 Million
-1,010,897 Reduced 2.73%
36,014,432 $864 Million
Q3 2023

Nov 13, 2023

BUY
$19.04 - $22.74 $31.2 Million - $37.2 Million
1,638,006 Added 4.63%
37,025,329 $809 Million
Q2 2023

Aug 11, 2023

SELL
$18.17 - $20.48 $15 Million - $16.9 Million
-826,851 Reduced 2.28%
35,387,323 $676 Million
Q1 2023

May 12, 2023

BUY
$16.3 - $19.41 $27.4 Million - $32.7 Million
1,683,880 Added 4.88%
36,214,174 $703 Million
Q4 2022

Feb 13, 2023

BUY
$14.96 - $17.39 $9.5 Million - $11 Million
634,974 Added 1.87%
34,530,294 $554 Million
Q3 2022

Nov 14, 2022

BUY
$15.68 - $22.27 $5.31 Million - $7.54 Million
338,589 Added 1.01%
33,895,320 $531 Million
Q2 2022

Aug 12, 2022

BUY
$17.44 - $23.16 $11.7 Million - $15.6 Million
672,170 Added 2.04%
33,556,731 $699 Million
Q1 2022

May 12, 2022

BUY
$17.03 - $22.67 $10.3 Million - $13.8 Million
607,183 Added 1.88%
32,884,561 $745 Million
Q4 2021

Feb 10, 2022

BUY
$15.84 - $21.88 $5.87 Million - $8.1 Million
370,331 Added 1.16%
32,277,378 $590 Million
Q3 2021

Nov 09, 2021

BUY
$16.3 - $21.14 $9.98 Million - $12.9 Million
612,104 Added 1.96%
31,907,047 $675 Million
Q2 2021

Aug 11, 2021

BUY
$17.95 - $25.56 $562 Million - $800 Million
31,294,943 New
31,294,943 $570 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.9B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.